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Abstract 
 
Background: Starfruit (Averrhoa carambola) leaves contain flavone derivatives that exhibit anti-hyperglycemic 
effects. This study aims to determine the effect of starfruit leaves in reducing glucose absorption in intestinal epithelial 
cells of mice. Methods: This study was done by performing perfusion on the small intestines of mice. The mice that 
were used in this study were divided into four groups. The control group was given glucose solution without infused 
starfruit leaves whereas, the remaining 3 groups were given 3 mmol (540 mg/dL) glucose solution with infused starfruit 
leaves of varying concentrations; 200, 400, and 600 mg/kg. Samples were collected at 0, 15th, 30th, 45th, and 60th minute. 
The sample was tested for glucose levels using spectrophotometry. Results: Test of significance showed a significant 
difference between the control group and the test group with p < 0.05. Conclusions: Starfruit leaves have a reduction 
effect towards glucose absorption in the small intestines in Wistar strains where the group using 600 mg/kg of infused 
starfruit leaves have the most significant effect as compared to other groups.  
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Introduction 
 
Studies about the usage of herbal based medicine to cure 
diseases has been done, including to decrease the blood 
glucose level.1 Previously known that the mechanism of 
glucose absorption can occur in a few ways; from glucose 
diffusion and protein transport. There are two type in 
glucose’s protein transport mechanism; Sodium-Glucose 
Transport Proteins (SGLT1) and Glucose Transporter 2 
(GLUT2).2-4 The mechanism of decreasing blood 
glucose could occur in a few ways. The fibers that are in 
herbal substances could inhibit glucose absorption.5-11 
Fibers are complicated to dissolve to smaller molecule 
because human’s intestine is lack of enzyme that can 
dissolve the fibers. Hence, the monosaccharides that 
bond with the fiber are difficult to absorb in human’s 
intestine.11 Aside from that, there are certain active 
substances that have glucose inhibition activity in the 
intestinal epithelial cells.12,13   
 
Starfruit leaves has flavone derivatives in the form of 
apigenin-6-C-β-L-fucopyranoside (Figure 1) and apigenin-
6-C-(2-O-α-L-rhamnopyranosyl)-β-1-fucopyranoside 
(Figure 2) that has a potential of anti-hyperglycemic 
effect.1,14,15 Even though it is known that starfruit leaves 
exhibits an anti-hyperglycemic effect, the molecular 
mechanism of starfruit leaves in lowering the blood 
glucose level is still exactly unknown. However, on 
previous study conclude that starfruit’s leaves infusion  
 
 
Figure 1. Apigenin-6-C-β-L-fucopyranoside1 
 
 
 
Figure 2.  Apigenin-6-C-(2-O-α-L-rhamnopyranosyl)-β-1-
fucopyranoside1 
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had effect on activity of glucose transportation on small 
intestine; apigenin-6-C-β-L-fucopyranoside and apigenin-
6-C-(2-O-α-L-rhamnopyranosyl)-β-1-fucopyranoside 
activate Phosphoinositide 3-Kinase inhibitor (PI3K 
inhibitor), Protein Kinase C inhibitor (PKC inhibitor), 
and Mitogen-activated Protein Kinase inhibitor (MEK 
inhibitor) to involve the glucose absorption activity.1 
Hence, this study has a purpose to observe the effect of 
infused starfruit leaves on glucose transport in the 
intestinal epithelial cells of mice. 
 
Methods 
 
This study was done in November 2015 in the 
Biochemistry Laboratory, Faculty of Medicine, Universitas 
Padjadjaran. The starfruit leaves were obtained from the 
Sekolah Ilmu Teknologi Hayati, Bandung Institute of 
Technology. The leaves were dried and infused using 
leaves that weighed 20, 40, and 60 g to produce 
sequential infusions with concentrations of 200, 400 and 
600 mg/kg of the mice weight. Each of the infused 
starfruit leaves was then mixed with 3mmol glucose 
solution with a ratio of 1:24 for the mice group that was 
given an infusion. Meanwhile, the control group was 
given distilled water (aqua dest) and 3 mmol glucose 
solution with the same ratio. For all subject enrolled in 
this study was approved by research ethics committee 
from Faculty of Medicine Universitas Padjadjaran with 
number 558/UN6.C1.3.2/KEPK/PN/2015. 
 
The mice used in this study were healthy, male mice 
with Wistar strains aged 3-4 months with a weight of 
200-300 g. The mice were adapted for a week in the 
Biochemistry Laboratory, Faculty of Medicine, Universitas 
Padjadjaran. During adaptation, the shelter are cleaned 
and mice are gave proper food and water. Mice that died 
before the study or during the data collection were not 
included in the sample group.  
 
In the study, 24 mice were divided into four groups. 
Researcher used Federer’s formula to get the smallest 
sample population. The mice were fasted for 8 hours then 
given an anesthetic which was intramuscular ketamine 0.4 
mL to anesthetized the mice during experiment. Then, 
cannulas were inserted 10 cm distally from the pylorus 
for the first cannula and 25 cm from the first cannula for 
the second cannula. The intestines of the mice were then 
cleaned using 0.96% NaCl solution three times. 
 
The tested solution was flowed through the small 
intestine of the mice using a perfusion device for 60 
minutes. Sample collection was done every 15 minutes 
from the 0 to the 60th minute. Samples were examined 
using the Trinder enzymatic method. The data analysis 
was done using the Shapiro-Wilk method to check the 
data distribution and the one-way Analysis of Variance 
(one-way ANOVA) method to calculate the significance 
of data. 
In this experiment, the researcher need to take notice the 
ethical aspect of animal experiment. In reduction aspect, 
researcher has used Federer’s formula to acquire the 
smallest population samples on each group. In refinement 
aspect, researcher has provided proper mice’s shelter 
and provision of food and water on adaptation phase. 
On data collection phase, researcher has used ketamine 
as anesthetic agent to relieve the mice from pain. And in 
replacement aspect, researcher has decided to use mice 
as population sample in order to use the lower animal 
levels. 
 
Results  
 
The comparison in glucose levels for the control group, 
200, 400, and 600 mg/kg of the mice weight was presented 
in Figure 3. Based on the Shapiro-Wilk data normality 
test, it was found that the data distribution of each group 
had a significance value of < 0.05 with an interpretation 
of normal data distribution. The value of glucose levels 
for the control group, 200, 400, and 600 mg/kg mice 
weight were chronologically presented in Table 1. 
 
Table 1. Glucose Level in Infusion 
 
 
Glucose Level in Infusion (mg/dL) 
15’ 30’ 45’ 60’ 
Control 1   25.397   17.063   13.492   12.302 
2   24.603   23.413   20.238   15.079 
3   40.079   38.889   29.762   20.635 
4   28.571   25.397   21.825   17.857 
5   34.921   31.349   26.190   19.841 
6   29.762   19.841   17.857   15.476 
Mean   30.556   25.991   21.561   16.865 
     
200 mg/kg 
mice 
weight 
1 112.698 111.508 108.730 107.143 
2 113.095 111.111 107.937 106.746 
3 112.698 110.317 108.333 105.556 
4 112.698 109.921   95.635   90.873 
5 135.714 111.508   95.635   88.095 
6 124.603 121.429 120.635 104.762 
Mean 118.585 112.632 106.151 100.529 
     
400 mg/kg 
mice 
weight 
1 142.857 141.270 139.286 119.841 
2 129.365 127.381 118.651 140.476 
3 146.825 119.048 114.286 109.921 
4 142.460 132.937 122.619 102.381 
5 137.302 130.556 129.365 123.810 
6 138.492 120.635 124.603 123.016 
Mean 139.550 128.637 124.801 119.907 
     
600 mg/kg 
mice 
weight 
1 122.619 121.429 120.238 117.460 
2 117.063 115.873 113.492 105.159 
3 121.825 118.651 112.302 110.317 
4 154.365 146.825 142.857 134.524 
5 157.540 150.794 149.206 144.444 
6 146.825 139.683 135.317 132.143 
Mean 136.706 132.209 128.902 124.008 
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Figure 3. Glucose Level in Infusion 
 
 
Discussion 
 
Based on previous studies, it is known that starfruit 
leaves have flavone derivatives that exhibit an effect in 
lowering glucose levels.1,15,16 The flavone derivatives 
found in starfruit leaves consisted of apigenin-6-C-β-L-
fucopyranoside and apigenin-6-C-(2-O-α-L-rhamno-
pyranosyl)-β-1-fucopyranoside15,16 Based on early studies 
about starfruit leaves; it was found that the starfruit leaf 
had an effect of reducing blood glucose level and 
increasing the entry of glucose into the soleus muscle of 
mice.1,14,17 The decreasing of blood glucose level and 
increasing of glucose entry into muscles are caused by the 
starfruit leaves’ effect towards glucose transportation 
and insulin release from β cells of the pancreas.1  
 
Based on Figure 3, there was a gradual decrease in 
blood glucose level from minute 0 to minute 60 in every 
group that showed that there was glucose absorption 
through the intestinal epithelial cells of mice in each 
group. In previous studies, there were results from the 
administration of starfruit leaves extract that intervened 
to decrease the glucose level based on measurements of 
mice blood samples.1 The lowest blood glucose level 
decrease by infusion was found in the test group with 
600 mg/kg infused starfruit leaves. A previous study 
also found that the administration of 400 mg/kg starfruit 
leaves extract had the most potent effect in lowering the 
blood glucose level in mice.1  
 
There is a significant difference between the administration 
of infused starfruit leaves and control solution on the 
decrease of glucose absorption. Based on that, the infused 
starfruit leaves inhibits the glucose absorption in the 
intestinal epithelial cells of mice. The glucose rate of 600 
mg/kg infused starfruit leaves during every 15 minutes 
had a higher value compared to the control group, 200 
and 400 mg/kg infused starfruit leaves. This is caused 
by the bigger values of active substances in 600 mg/kg 
infused starfruit leaves that led to a bigger intervention 
in glucose absorption compared to other groups. The 
limitation of this study is that the researcher does not 
have definite knowledge about the molecular mechanism 
of infused starfruit leaves on glucose transport in the 
intestinal epithelial cells of mice. 
 
Conclusions 
 
The conclusion of this study is that the administration of 
infused starfruit leaves decreases glucose absorption in 
the intestinal epithelial cells of mice with the highest 
rate of glucose absorption occurring in the first 15 
minutes. The 600 mg/kg infused starfruit leaves had the 
highest inhibitory effect on glucose absorption compared 
to the control group and other infusions. 
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